Home Artists Posts Import Register

Content

For those that like to keep track of the business side of the psychedelics industry this article may be of interest.  Companies focused on psychedelics continue to receive strong funding and soon the public will be able to invest directly as well.  That said, you should be very cautious as it is still very early for this fledgling industry and high risk from an investment standpoint.  Still there is quite a bit of promise here, especially in light of the early encouraging results in FDA trials.

Files

Move over, pot: Psychedelic drug companies gear up to list on Canadian stock exchanges

The first companies developing medical treatments from psychedelic drugs like LSD, ketamine and the active ingredient in magic mushrooms are gearing up to list on Canadian stock exchanges. Mind Medicine Inc., which is undertaking clinical trials of psychedelic-based drugs, intends to list on Toronto's NEO Exchange by the first week of March, said JR Rahn, the company's co-founder and director.

Comments

No comments found for this post.